| MeSH term | MeSH ID | Detail |
|---|---|---|
| Fever | D005334 | 35 associated lipids |
| Fibromyalgia | D005356 | 4 associated lipids |
| Glioma | D005910 | 112 associated lipids |
| Hepatitis | D006505 | 11 associated lipids |
| Hyperalgesia | D006930 | 42 associated lipids |
| Hyperemia | D006940 | 25 associated lipids |
| Hyperinsulinism | D006946 | 27 associated lipids |
| Hyperkinesis | D006948 | 11 associated lipids |
| Hypersensitivity, Delayed | D006968 | 43 associated lipids |
| Hypertension | D006973 | 115 associated lipids |
Anandamide
Anandamide is a lipid of Fatty Acyls (FA) class. Anandamide is associated with abnormalities such as Dehydration. The involved functions are known as Process, Phenomenon, Phosphorylation, Catabolic Process and Gene Expression. Anandamide often locates in Nuchal region, Microglial and Hepatic. The associated genes with Anandamide are SGPL1 gene, SPTLC1 gene, RPSA gene, KDSR gene and SMPD1 gene. The related lipids are Sphingolipids, Lipopolysaccharides, Lysophospholipids, LYSO-PC and lysophosphatidylethanolamine.
Cross Reference
Introduction
To understand associated biological information of Anandamide, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Anandamide?
Anandamide is suspected in Dehydration and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Anandamide
PubChem Associated disorders and diseases
What pathways are associated with Anandamide
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Anandamide?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Anandamide?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Anandamide?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Anandamide?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Anandamide?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Anandamide
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Panagis G et al. | Behavioral pharmacology of cannabinoids with a focus on preclinical models for studying reinforcing and dependence-producing properties. | 2008 | Curr Drug Abuse Rev | pmid:19630731 |
| Ortar G et al. | Carbamoyl tetrazoles as inhibitors of endocannabinoid inactivation: a critical revisitation. | 2008 | Eur J Med Chem | pmid:17452063 |
| Xiong W et al. | Anandamide inhibition of 5-HT3A receptors varies with receptor density and desensitization. | 2008 | Mol. Pharmacol. | pmid:17993512 |
| Hill MN et al. | Prolonged glucocorticoid treatment decreases cannabinoid CB1 receptor density in the hippocampus. | 2008 | Hippocampus | pmid:18058925 |
| Egertová M et al. | Localization of N-acyl phosphatidylethanolamine phospholipase D (NAPE-PLD) expression in mouse brain: A new perspective on N-acylethanolamines as neural signaling molecules. | 2008 | J. Comp. Neurol. | pmid:18067139 |
| Rossi C et al. | Endocannabinoids in platelets of chronic migraine patients and medication-overuse headache patients: relation with serotonin levels. | 2008 | Eur. J. Clin. Pharmacol. | pmid:18004553 |
| Di Marzo V et al. | The role of endocannabinoids in the regulation of gastric emptying: alterations in mice fed a high-fat diet. | 2008 | Br. J. Pharmacol. | pmid:18223666 |
| Simon GM and Cravatt BF | Anandamide biosynthesis catalyzed by the phosphodiesterase GDE1 and detection of glycerophospho-N-acyl ethanolamine precursors in mouse brain. | 2008 | J. Biol. Chem. | pmid:18227059 |
| Burstein S | The elmiric acids: biologically active anandamide analogs. | 2008 | Neuropharmacology | pmid:18187165 |
| Gorzalka BB et al. | Endocannabinoid modulation of male rat sexual behavior. | 2008 | Psychopharmacology (Berl.) | pmid:17694389 |
| Rueda-Orozco PE et al. | A potential function of endocannabinoids in the selection of a navigation strategy by rats. | 2008 | Psychopharmacology (Berl.) | pmid:17805517 |
| Engeli S et al. | Peripheral endocannabinoid system activity in patients treated with sibutramine. | 2008 | Obesity (Silver Spring) | pmid:18356837 |
| Kurtuncu M et al. | Effects of cocaine in 5-lipoxygenase-deficient mice. | 2008 | J Neural Transm | pmid:18327533 |
| Habayeb OM et al. | Plasma anandamide concentration and pregnancy outcome in women with threatened miscarriage. | 2008 | JAMA | pmid:18334688 |
| Oláh M et al. | The role of endocannabinoids in the regulation of luteinizing hormone and prolactin release. Differences between the effects of AEA and 2AG. | 2008 | Mol. Cell. Endocrinol. | pmid:18308464 |
| Potvin S et al. | Endogenous cannabinoids in patients with schizophrenia and substance use disorder during quetiapine therapy. | 2008 | J. Psychopharmacol. (Oxford) | pmid:18308802 |
| Wise LE et al. | Evaluation of fatty acid amides in the carrageenan-induced paw edema model. | 2008 | Neuropharmacology | pmid:17675189 |
| Richardson D et al. | Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis. | 2008 | Arthritis Res. Ther. | pmid:18416822 |
| Farrell EK and Merkler DJ | Biosynthesis, degradation and pharmacological importance of the fatty acid amides. | 2008 | Drug Discov. Today | pmid:18598910 |
| Terry G et al. | Positron emission tomography imaging using an inverse agonist radioligand to assess cannabinoid CB1 receptors in rodents. | 2008 | Neuroimage | pmid:18456516 |
| Yang Z et al. | Subunit-specific modulation of glycine receptors by cannabinoids and N-arachidonyl-glycine. | 2008 | Biochem. Pharmacol. | pmid:18755158 |
| Wang J et al. | Expression and secretion of N-acylethanolamine-hydrolysing acid amidase in human prostate cancer cells. | 2008 | J. Biochem. | pmid:18806270 |
| Murillo-RodrÃguez E et al. | The anandamide membrane transporter inhibitor, VDM-11, modulates sleep and c-Fos expression in the rat brain. | 2008 | Neuroscience | pmid:18822353 |
| Woo DH et al. | Direct activation of transient receptor potential vanilloid 1(TRPV1) by diacylglycerol (DAG). | 2008 | Mol Pain | pmid:18826653 |
| DeMorrow S et al. | The endocannabinoid anandamide inhibits cholangiocarcinoma growth via activation of the noncanonical Wnt signaling pathway. | 2008 | Am. J. Physiol. Gastrointest. Liver Physiol. | pmid:18832445 |
| Bambico FR and Gobbi G | The cannabinoid CB1 receptor and the endocannabinoid anandamide: possible antidepressant targets. | 2008 | Expert Opin. Ther. Targets | pmid:18851692 |
| Khasabova IA et al. | A decrease in anandamide signaling contributes to the maintenance of cutaneous mechanical hyperalgesia in a model of bone cancer pain. | 2008 | J. Neurosci. | pmid:18971457 |
| Hill MN et al. | Differential effects of the antidepressants tranylcypromine and fluoxetine on limbic cannabinoid receptor binding and endocannabinoid contents. | 2008 | J Neural Transm | pmid:18974922 |
| Fowler CJ and Ghafouri N | Does the hydrolysis of 2-arachidonoylglycerol regulate its cellular uptake? | 2008 | Pharmacol. Res. | pmid:18675915 |
| Hashiguchi T et al. | Systematic evaluation of nitric oxide, tetrahydrobiopterin, and anandamide levels in a porcine model of endotoxemia. | 2008 | J Anesth | pmid:18685926 |
| Lisboa SF et al. | Activation of cannabinoid CB1 receptors in the dorsolateral periaqueductal gray induces anxiolytic effects in rats submitted to the Vogel conflict test. | 2008 | Eur. J. Pharmacol. | pmid:18691568 |
| Currie S et al. | IP(3)R-mediated Ca(2+) release is modulated by anandamide in isolated cardiac nuclei. | 2008 | J. Mol. Cell. Cardiol. | pmid:18692061 |
| Turco MY et al. | High levels of anandamide, an endogenous cannabinoid, block the growth of sheep preimplantation embryos by inducing apoptosis and reversible arrest of cell proliferation. | 2008 | Hum. Reprod. | pmid:18614613 |
| Maccarrone M | Anandamide as a marker of human disease. | 2008 | JAMA | pmid:18632539 |
| Hill MN et al. | Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment. | 2008 | J. Neurochem. | pmid:18643796 |
| Kudo R and Hatake K | [Effect of ethanol on anandamide-induced sensory nerve dependent vasorelaxation (the second report)]. | 2008 | Nihon Arukoru Yakubutsu Igakkai Zasshi | pmid:18646646 |
| Maione S et al. | Antinociceptive effects of tetrazole inhibitors of endocannabinoid inactivation: cannabinoid and non-cannabinoid receptor-mediated mechanisms. | 2008 | Br. J. Pharmacol. | pmid:18660824 |
| Fowler CJ | "The tools of the trade"--an overview of the pharmacology of the endocannabinoid system. | 2008 | Curr. Pharm. Des. | pmid:18781976 |
| McPartland JM et al. | Cannabimimetic effects modulated by cholinergic compounds. | 2008 | Addict Biol | pmid:18782385 |
| Ferreri C et al. | Synthesis of all-trans anandamide: a substrate for fatty acid amide hydrolase with dual effects on rabbit platelet activation. | 2008 | Bioorg. Med. Chem. | pmid:18782671 |
| Rácz I et al. | Anandamide effects on 5-HT(3) receptors in vivo. | 2008 | Eur. J. Pharmacol. | pmid:18775693 |
| Placzek EA et al. | Mechanisms for recycling and biosynthesis of endogenous cannabinoids anandamide and 2-arachidonylglycerol. | 2008 | J. Neurochem. | pmid:18778304 |
| Qin N et al. | TRPV2 is activated by cannabidiol and mediates CGRP release in cultured rat dorsal root ganglion neurons. | 2008 | J. Neurosci. | pmid:18550765 |
| Lehtonen M et al. | Mass-spectrometric identification of anandamide and 2-arachidonoylglycerol in nematodes. | 2008 | Chem. Biodivers. | pmid:19035572 |
| Bjursell M et al. | Acutely reduced locomotor activity is a major contributor to Western diet-induced obesity in mice. | 2008 | Am. J. Physiol. Endocrinol. Metab. | pmid:18029443 |
| Williams MA et al. | The group IV afferent neuron expresses multiple receptor alterations in cardiomyopathyic rats: evidence at the cannabinoid CB1 receptor. | 2008 | J. Physiol. (Lond.) | pmid:18063665 |
| Justinova Z et al. | Fatty acid amide hydrolase inhibition heightens anandamide signaling without producing reinforcing effects in primates. | 2008 | Biol. Psychiatry | pmid:18814866 |
| Muccioli GG and Stella N | An optimized GC-MS method detects nanomolar amounts of anandamide in mouse brain. | 2008 | Anal. Biochem. | pmid:17981259 |
| Thiemann G et al. | The role of the CB1 cannabinoid receptor and its endogenous ligands, anandamide and 2-arachidonoylglycerol, in amphetamine-induced behavioural sensitization. | 2008 | Behav. Brain Res. | pmid:17988751 |
| Correa F et al. | Anandamide inhibits IL-12p40 production by acting on the promoter repressor element GA-12: possible involvement of the COX-2 metabolite prostamide E(2). | 2008 | Biochem. J. | pmid:17961121 |